Scientists probe mystery of light therapy for transplant complications
NCT ID NCT03438643
Summary
This study aimed to understand how a light-based blood treatment called extracorporeal photopheresis (ECP) works in patients with chronic graft-versus-host disease (cGVHD). Researchers followed 8 patients receiving ECP along with standard steroid medications to see how the treatment changed their immune cells. The main goal was to learn about the biological mechanisms behind ECP rather than to test its effectiveness as a new treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GRAFT -VERSUS-HOST-DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hôpital Claude Huriez, CHU
Lille, France
Conditions
Explore the condition pages connected to this study.